Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Alex De Caluwe

Université libre de Bruxelles (ULB)

Belgium

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Immunology

40%

Pharmacotherapy

50%

Radiation Therapy

60%

Cancer Therapy

60%

Oncology

50%

Tumor Immunology

40%

Antibody Therapy

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles13

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma

Article Link

Year:

2023

Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers

Article Link

Year:

2023

Immunotherapy in breast cancer: an overview of current strategies and perspectives

Article Link

Year:

2023

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges

Article Link

Year:

2023

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

Article Link

Year:

2023

Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT

Article Link

Year:

2023

Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups

Article Link

Year:

2023

Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer

Article Link

Year:

2022

Tumour infiltrating lymphocytes and ductal carcinoma in situ: The art of thinking counterintuitively

Article Link

Year:

2022

Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT.

Article Link

Year:

2022

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

Article Link

Year:

2021

Split-VMAT technique to control the deep inspiration breath hold time for breast cancer radiotherapy

Article Link

Year:

2021

Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: Differences between tangential beam and VMAT

Article Link

Year:

2021

Collaborators10

Laurence Buisseret

Université libre de Bruxelles (ULB)

BELGIUM

Emanuela Romano

PSL Research University

FRANCE

Christos Sotiriou

Université libre de Bruxelles

BELGIUM

Mattia Rediti

Université libre de Bruxelles (ULB)

BELGIUM

Evandro de Azambuja

Institut Jules Bordet

BELGIUM

Elisa Agostinetto

Institut Jules Bordet

BELGIUM

Sandra Tuyaerts

Vrije Universiteit Brussel

BELGIUM

C. Florin Pop

Université libre de Bruxelles

BELGIUM

Dirk Van Gestel

Université libre de Bruxelles

BELGIUM

Trine Tramm

Associate Professor, Consultant Pathologist

Aarhus University

DENMARK

How do I reach out?

Meet Kite AI